Proteomics reveals dynamic metabolic changes in human hematopoietic stem progenitor cells from fetal to adulthood.

Autor: Xiong M; Senior Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China.; Medical School of the Chinese PLA General Hospital, Beijing, 100039, China., Xiu Y; Senior Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China.; College of Veterinary Medicine, Shanxi Agricultural University, Taigu, 030801, Shanxi, China., Long J; Senior Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China., Zhao X; Senior Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China., Wang Q; School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, 311399, China., Yang H; College of Veterinary Medicine, Shanxi Agricultural University, Taigu, 030801, Shanxi, China., Yu H; Senior Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China.; Medical School of the Chinese PLA General Hospital, Beijing, 100039, China., Bian L; Department of Gynecology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China., Ju Y; Department of Gynecology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China., Yin H; Department of Gynecology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China., Hou Q; Department of Obstetrics and Gynecology, PLA Rocket Force Characteristic Medical Center, Beijing, 100088, China., Liang F; Senior Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China., Liu N; Senior Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China., Chen F; Medical School of the Chinese PLA General Hospital, Beijing, 100039, China., Fan R; College of Veterinary Medicine, Shanxi Agricultural University, Taigu, 030801, Shanxi, China., Sun Y; Senior Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China. yuyingsun001@sina.com., Zeng Y; Senior Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China. zengzengyang89@126.com.; Medical School of the Chinese PLA General Hospital, Beijing, 100039, China. zengzengyang89@126.com.; School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, 311399, China. zengzengyang89@126.com.
Jazyk: angličtina
Zdroj: Stem cell research & therapy [Stem Cell Res Ther] 2024 Sep 15; Vol. 15 (1), pp. 303. Date of Electronic Publication: 2024 Sep 15.
DOI: 10.1186/s13287-024-03930-x
Abstrakt: Background: Hematopoietic stem progenitor cells (HSPCs) undergo phenotypical and functional changes during their emergence and development. Although the molecular programs governing the development of human hematopoietic stem cells (HSCs) have been investigated broadly, the relationships between dynamic metabolic alterations and their functions remain poorly characterized.
Methods: In this study, we comprehensively described the proteomics of HSPCs in the human fetal liver (FL), umbilical cord blood (UCB), and adult bone marrow (aBM). The metabolic state of human HSPCs was assessed via a Seahorse assay, RT‒PCR, and flow cytometry-based metabolic-related analysis. To investigate whether perturbing glutathione metabolism affects reactive oxygen species (ROS) production, the metabolic state, and the expansion of human HSPCs, HSPCs were treated with buthionine sulfoximine (BSO), an inhibitor of glutathione synthetase, and N-acetyl-L-cysteine (NAC).
Results: We investigated the metabolomic landscape of human HSPCs from the fetal, perinatal, and adult developmental stages by in-depth quantitative proteomics and predicted a metabolic switch from the oxidative state to the glycolytic state during human HSPC development. Seahorse assays, mitochondrial activity, ROS level, glucose uptake, and protein synthesis rate analysis supported our findings. In addition, immune-related pathways and antigen presentation were upregulated in UCB or aBM HSPCs, indicating their functional maturation upon development. Glutathione-related metabolic perturbations resulted in distinct responses in human HSPCs and progenitors. Furthermore, the molecular and immunophenotypic differences between human HSPCs at different developmental stages were revealed at the protein level for the first time.
Conclusion: The metabolic landscape of human HSPCs at three developmental stages (FL, UCB, and aBM), combined with proteomics and functional validations, substantially extends our understanding of HSC metabolic regulation. These findings provide valuable resources for understanding human HSC function and development during fetal and adult life.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje